Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
GSH administration was associated with shorter OS and DFS in breast cancer patients, with a median survival of 68 months in the GSH group, compared to 74 months in the Non-GSH group ( P = 0.023)
317 Neurodegenerative disorders and protein homeostasis Neurodegenerative disorders (NDDs) are characterized by a progressive loss of neuronal structure and function, leading to cognitive, motor, and behavioral impairments
3.2.2 Tacrolimus Post-transplant DM is seen in 30% of solid organ transplant recipients
First, rates are highest during dose escalation and usually improve with time on a steady dose
US$ 27.01
US$ 21.92
US$ 25.32
US$ 22.10
